Cardiovascular Research Institute, University of California, San Francisco San Francisco CA USA.
Division of Cardiology University of California, San Francisco San Francisco CA USA.
J Am Heart Assoc. 2023 Dec 5;12(23):e032969. doi: 10.1161/JAHA.123.032969. Epub 2023 Nov 28.
Marijuana leaf vaporizers, which heat plant material and sublimate Δ-9-tetrahydrocannabinol without combustion, are popular alternatives to smoking cannabis that are generally perceived to be less harmful. We have shown that smoke from tobacco and marijuana, as well as aerosol from e-cigarettes and heated tobacco products, impair vascular endothelial function in rats measured as arterial flow-mediated dilation (FMD).
We exposed 8 rats per group to aerosol generated by 2 vaporizer systems (Volcano and handheld Yocan) using marijuana with varying Δ-9-tetrahydrocannabinol levels, in a single pulsatile exposure session of 2 s/min over 5 minutes, and measured changes in FMD. To model secondhand exposure, we exposed rats for 1 minute to diluted aerosol approximating release of uninhaled Volcano aerosol into typical residential rooms. Exposure to aerosol from marijuana with and without cannabinoids impaired FMD by ≈50%. FMD was similarly impaired by aerosols from Yocan (237 °C), and from Volcano at both its standard temperature (185 °C) and the minimum sublimation temperature of Δ-9-tetrahydrocannabinol (157 °C), although the low-temperature aerosol condition did not effectively deliver Δ-9-tetrahydrocannabinol to the circulation. Modeled secondhand exposure based on diluted Volcano aerosol also impaired FMD. FMD was not affected in rats exposed to clean air or water vapor passed through the Volcano system.
Acute direct exposure and modeled secondhand exposure to marijuana leaf vaporizer aerosol, regardless of cannabinoid concentration or aerosol generation temperature, impair endothelial function in rats comparably to marijuana smoke. Our findings indicate that use of leaf vaporizers is unlikely to reduce the vascular risk burden of smoking marijuana.
大麻叶汽化器加热植物材料并升华 Δ-9-四氢大麻酚而不燃烧,是吸食大麻的流行替代品,通常被认为危害较小。我们已经表明,烟草和大麻的烟雾以及电子烟和加热烟草产品的气溶胶会损害大鼠的血管内皮功能,其测量方法为动脉血流介导的扩张(FMD)。
我们将每组 8 只大鼠暴露于通过 2 种汽化器系统(Volcano 和手持式 Yocan)产生的气溶胶中,使用大麻,其 Δ-9-四氢大麻酚含量不同,在 5 分钟内以 2 秒/分钟的单一脉冲暴露于气溶胶中,测量 FMD 的变化。为了模拟二手暴露,我们将大鼠暴露于稀释的气溶胶中 1 分钟,该气溶胶模拟了未吸入的 Volcano 气溶胶释放到典型的住宅房间中。大麻中有无大麻素的气溶胶暴露均使 FMD 降低约 50%。Yocan(237°C)的气溶胶、Volcano 的标准温度(185°C)和 Δ-9-四氢大麻酚的最低升华温度(157°C)下的气溶胶也使 FMD 受损,尽管低温气溶胶条件并未有效将 Δ-9-四氢大麻酚输送到循环中。基于稀释的 Volcano 气溶胶的模拟二手暴露也使 FMD 受损。暴露于清洁空气或通过 Volcano 系统传递的水蒸气的大鼠的 FMD 不受影响。
急性直接暴露和模拟的二手暴露于大麻叶汽化器气溶胶,无论大麻素浓度或气溶胶产生温度如何,都会使大鼠的内皮功能受损,与大麻烟雾的作用相当。我们的研究结果表明,使用叶片汽化器不太可能降低吸食大麻的血管风险负担。